← Screener

BAXBaxter International

Health care · Medical Instruments · NYSE

Compare with peers → Embed

Filings with the SEC since Apr 7, 2016

1,001 filings, 3 in the last 30 days

SEC filing index

Latest annual reportOpen ↗

Feb 12, 2026

10-K, period to Dec 31, 2025

Latest quarterly reportOpen ↗

Oct 29, 2026

10-Q, period to Sep 30, 2026

Latest current reportOpen ↗

Oct 29, 2026

8-K: Quarterly results, Other events

Filed in the last 30 days

of 1,001 in all

Timeline

Every filing on one line

1 yr 2 yr 3 yr

Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)

20252026

All 43 events

Oct 29, 20268-K Quarterly results, Other events 8-K items 2.02, 8.01
Oct 29, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026
Aug 19, 2026Officer CEO, CFO and CAO change (the “Company”) appointed John Rogers as Executive Vice President and Chief Financial Officer (“CFO”), effective as of October 1, 2026 (the “Transition Date”).
Aug 18, 20268-K Material agreement signed, Other events 8-K items 1.01, 8.01
Aug 4, 20268-K Other events 8-K item 8.01
Aug 4, 20268-K Director or officer change 8-K item 5.02
Jul 30, 20268-K Quarterly results, Other events 8-K items 2.02, 8.01
Jul 30, 202610-Q Quarterly report (10-Q) period ended Jun 30, 2026
Jul 14, 20268-K Regulation FD disclosure 8-K item 7.01
May 8, 20268-K Director or officer change, Bylaws or fiscal year changed, Shareholder vote results 8-K items 5.02, 5.03, 5.07
Apr 30, 20268-K Quarterly results, Other events 8-K items 2.02, 8.01
Apr 30, 202610-Q Quarterly report (10-Q) period ended Mar 31, 2026
Mar 19, 20268-K Regulation FD disclosure 8-K item 7.01
Mar 16, 2026Officer CFO and CAO change (the “Company”) announced that, as of such date (the “Transition Date”), Joel Grade’s service as Executive Vice President and Chief Financial Officer (“CFO”) of the Company has ceased and, as of such date, Mr.
Feb 12, 20268-K Quarterly results, Director or officer change, Other events 8-K items 2.02, 5.02, 8.01
Feb 12, 202610-K Annual report (10-K) period ended Dec 31, 2025
Dec 22, 20258-K Other events 8-K item 8.01
Dec 4, 20258-K Material agreement signed, Material agreement ended, New debt or obligation, Other events 8-K items 1.01, 1.02, 2.03, 8.01
Nov 25, 20258-K Material agreement signed 8-K item 1.01
Nov 19, 20258-K Other events 8-K item 8.01
Nov 19, 20258-K Other events 8-K item 8.01
Nov 12, 20258-K Director or officer change 8-K item 5.02
Nov 4, 202510-Q Quarterly report (10-Q) period ended Sep 30, 2025
Oct 30, 20258-K Quarterly results 8-K item 2.02
Oct 21, 20258-K Director or officer change 8-K item 5.02
Aug 5, 202510-Q Quarterly report (10-Q) period ended Jun 30, 2025
Jul 31, 20258-K Quarterly results 8-K item 2.02
Jul 7, 20258-K Director or officer change, Regulation FD disclosure 8-K items 5.02, 7.01
Jun 12, 20258-K Material agreement signed, Material agreement ended, New debt or obligation 8-K items 1.01, 1.02, 2.03
May 8, 20258-K Shareholder vote results 8-K item 5.07
May 6, 202510-Q Quarterly report (10-Q) period ended Mar 31, 2025
May 1, 20258-K Quarterly results 8-K item 2.02
Mar 14, 20258-K Regulation FD disclosure 8-K item 7.01
Feb 25, 2025Offering Shelf registration: shares and other securities, amount not fixed S-3ASR · Under the shelf registration process, we may, at any time and from time to time, in one or more offerings, sell common stock, preferred stock, debt securities, warrants and units up to an indeterminate total dollar amount under this prospectus.
Feb 21, 202510-K Annual report (10-K) period ended Dec 31, 2024
Feb 20, 20258-K Quarterly results 8-K item 2.02
Feb 6, 20258-K Regulation FD disclosure (amended) 8-K item 7.01
Feb 3, 2025Officer CEO and COO change Transition of José Almeida as CEO and Chair; Appointment of Brent Shafer as Interim CEO and Chair
Feb 3, 20258-K Acquisition or sale of assets completed, Director or officer change 8-K items 2.01, 5.02
Jan 31, 20258-K Director or officer change 8-K item 5.02
Nov 27, 20248-K Bylaws or fiscal year changed 8-K item 5.03
Nov 22, 20248-K Director or officer change 8-K item 5.02
Nov 12, 202410-Q Quarterly report (10-Q) period ended Sep 30, 2024

From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).

Every filing

Newest first, by kind

Each form links to sec.gov

All 1001 Annual & quarterly 43 Current reports (8-K) 148 Insiders 606 Proxy & votes 29 Big owners (13D/13G) 56 Shares & debt offered 25 SEC letters 12 Other 82

Filed	Form	What it is	Period
Apr 29, 2026	DEFA14A	Extra proxy material		all files
Mar 23, 2026	DEFA14A	Extra proxy material		all files
Mar 23, 2026	DEF 14A	Proxy statement	May 5, 2026	all files
Mar 13, 2026	PRE 14A		May 5, 2026	all files
Mar 25, 2025	DEF 14A	Proxy statement	May 6, 2025	all files
Mar 25, 2025	DEFA14A	Extra proxy material		all files
Mar 27, 2024	DEFA14A	Extra proxy material		all files
Mar 25, 2024	DEFA14A	Extra proxy material		all files
Mar 25, 2024	DEF 14A	Proxy statement	May 7, 2024	all files
Mar 14, 2024	PRE 14A		May 7, 2024	all files
Mar 23, 2023	DEFA14A	Extra proxy material		all files
Mar 23, 2023	DEF 14A	Proxy statement		all files
Mar 23, 2022	PX14A6G	Shareholder's proxy letter		all files
Mar 21, 2022	DEFA14A	Extra proxy material		all files
Mar 21, 2022	DEF 14A	Proxy statement	May 3, 2022	all files
Mar 10, 2022	PRE 14A		May 3, 2022	all files
Mar 31, 2021	PX14A6G	Shareholder's proxy letter		all files
Mar 22, 2021	DEFA14A	Extra proxy material		all files
Mar 22, 2021	DEF 14A	Proxy statement	May 4, 2021	all files
Apr 21, 2020	DEFA14A	Extra proxy material		all files
Mar 31, 2020	DEFA14A	Extra proxy material		all files
Mar 17, 2020	DEFA14A	Extra proxy material		all files
Mar 17, 2020	DEF 14A	Proxy statement	May 5, 2020	all files
Mar 26, 2019	DEFA14A	Extra proxy material		all files
Mar 26, 2019	DEF 14A	Proxy statement	May 7, 2019	all files
Mar 23, 2018	DEFA14A	Extra proxy material		all files
Mar 23, 2018	DEF 14A	Proxy statement	May 8, 2018	all files
Mar 17, 2017	DEFA14A	Extra proxy material		all files
Mar 17, 2017	DEF 14A	Proxy statement	May 2, 2017	all files

Show the other 4 filings on this page

Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.

Next Earnings releases →